RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Cancer Research Institute
C

Cancer Research Institute portfolio

Cancer Research Institute has 2 portfolio companies on record at Recent Funding.

Type: Investor.
Portfolio on Recent Funding: 2.
Deals, last 12 months: 0.
Capital in their rounds: $57M.
Latest deal: Cartography Biosciences · Jul 20, 2022.
About this page

Its most recent investment on record is Cartography Biosciences's $57M Series A round in July 2022, alongside Wing VC, ARTIS Ventures, Gaingels and 5 others. By category, its portfolio leans toward Health and bio (2).

What Cancer Research Institute invests in

How Cancer Research Institute invests

StageDealsCapital in rounds
Series A 1 100%$57M

Cancer Research Institute portfolio companies

CompanyRound with Cancer Research InstituteTotal raisedLatest raise
CCartography Biosciences
Health and bio
Series A · $57M$124MOct 2, 2025
Series B+
OOverT Bio
Health and bio
backer$16MMay 6, 2024
Seed

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Share is of the 1 round on Recent Funding that name Cancer Research Institute. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists Cancer Research Institute, which is a subset of its real portfolio. API: /api/v1/investors/cancer-research-institute (get a free API key). More: the most active VC firms and new venture capital funds.